Successful repeated hepatic gene delivery in non-human primates achieved with AAV5 by use of immune adsorption

被引：0
|
作者：
Salas, D. [1 ]
Kwikkers, K. [2 ]
Majowicz, A. [2 ]
Zabaleta, N. [1 ]
Petry, H. [2 ]
Ferreira, V. [2 ]
Gonzalez-Aseguinolaza, G. [1 ]
机构：
[1] CIMA, Navarra, Spain
[2] UniQure Biopharma BV, Amsterdam, Netherlands
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P316
引用
收藏
页码：A102 / A103
页数：2
相关论文
共 50 条
  • [1] Successful Repeated Hepatic Gene Delivery in Non-Human Primates Achieved with AAV5 by Use of Immune Adsorption
    Salas, David
    Kwikkers, Karin
    Majowicz, Anna
    Zabaleta, Nerea
    Petry, Harald
    Gonzalez Aseguinolaza, Gloria
    Ferreira, Valerie
    MOLECULAR THERAPY, 2017, 25 (05) : 183 - 183
  • [2] Successful Repeated Hepatic Gene Delivery in Mice and Non-Human Primates Achieved by Sequential Administration of AAV5 and AAV1 Vector Serotypes
    Majowicz, Anna
    Salas, David
    Zabaleta, Nerea
    Rodriguez-Garcia, Estefania
    Gonzalez Aseguinolaza, Gloria
    Petry, Harald
    Ferreira, Valerie
    MOLECULAR THERAPY, 2016, 24 : S277 - S277
  • [3] Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1
    Majowicz, Anna
    Salas, David
    Zabaleta, Nerea
    Rodriguez-Garcia, Estefania
    Gonzalez-Aseguinolaza, Gloria
    Petry, Harald
    Ferreira, Valerie
    MOLECULAR THERAPY, 2017, 25 (08) : 1831 - 1842
  • [4] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
  • [5] Comparable efficiency of photoreceptor transduction by AAV2tYF, AAV5 and AAV8 in non-human primates
    Shearman, M. S.
    Song, C. J.
    Ye, G.
    Timmers, A. M.
    Newmark, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A153 - A153
  • [6] Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
    Colle, Marie-Anne
    Piguet, Francoise
    Bertrand, Lise
    Raoul, Sylvie
    Bieche, Ivan
    Dubreil, Laurence
    Sloothaak, Didi
    Bouquet, Celine
    Moullier, Philippe
    Aubourg, Patrick
    Cherel, Yan
    Cartier, Nathalie
    Sevin, Caroline
    HUMAN MOLECULAR GENETICS, 2010, 19 (01) : 147 - 158
  • [7] Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
    Liu, Mengping
    Cook, Erica
    Dai, Yanshan
    Ehlert, Erich
    du Plessis, Francois
    Lubelski, Jacek
    Sleczka, Bogdan G.
    Shipkova, Petia
    Li, Zhuyin
    Gamse, Joshua
    Gordon, David
    Adam, Leonard P.
    Levesque, Paul C.
    Banks, Glen B.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2025, 33 (01)
  • [8] Trophism of AAV2 and AAV5 vectors in the non-human primate retina
    Lotery, AJ
    Derksen, TA
    Russell, SR
    Mullins, RF
    Yang, GS
    Kopp, KK
    Eastman, CG
    Stone, EM
    Davidson, BL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1308 - U1308
  • [9] Subfoveal Injections in Non-Human Primates: Safety and Efficacy Following Administration of a Photoreceptor-Targeted AAV5
    Boyd, Ryan F.
    Bartoe, Joshua T.
    Vihtelic, Thomas S.
    Boye, Sanford L.
    Boye, Shannon Elizabeth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient
    Journou, Malo
    Devaux, Marie
    Jaulin, Nicolas
    Pichard, Virginie
    Segovia, Mercedes
    Moreau, Aurelie
    Le Duff, Johanne
    Cuturi, Maria Cristina
    Guilbaud, Mickael
    Adjali, Oumeya
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2025, 33 (01)
12345